Stay updated on Crenezumab Long-Term Safety in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Crenezumab Long-Term Safety in Alzheimer's Clinical Trial page.
Latest updates to the Crenezumab Long-Term Safety in Alzheimer's Clinical Trial page
- Check2 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in its functionality.SummaryDifference0.2%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check38 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.SummaryDifference2%
- Check53 days agoChange DetectedThe website has added new features, while several detailed options for data download and participant information have been removed.SummaryDifference3%
- Check60 days agoChange DetectedSeveral key health-related links, including those for Alzheimer's disease and genetics resources, have been removed from the website.SummaryDifference0.4%
- Check67 days agoChange DetectedThe website has been updated to version 2.12.2, with new resources added related to Alzheimer's disease, including links to MedlinePlus and NIH, as well as clinical trial documents.SummaryDifference3%
Stay in the know with updates to Crenezumab Long-Term Safety in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenezumab Long-Term Safety in Alzheimer's Clinical Trial page.